Clinical implications of HIV dynamics and drug resistance in macrophages

Journal of Biological Regulators and Homeostatic Agents

Volumn 12, Issue SUPPL. 2, 1998, Pages 23-27

  Aquaro, S ^a   Calio R ^a   Balestra, E ^a   Bagnarelli, P ^b   Cenci, A ^a   Bertoli, A ^a   Tavazzi, B ^a   Di Pierro, D ^a   Francesconi, M ^c   Abdelahad, D ^c   Perno, C F ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^c Frascati Hospital   (Italy)

Author keywords

AIDS; Lymphocytes; Macrophages; Protease inhibitors; Therapy; Virus resistance

Indexed keywords

ANTIVIRUS AGENT; NUCLEOTIDE; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE;

CENTRAL NERVOUS SYSTEM; CONFERENCE PAPER; DRUG EFFICACY; ENZYME ACTIVITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIFE CYCLE; LYMPH NODE; LYMPHOCYTE; MACROPHAGE; TESTIS; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS; RNA VIRUSES;

EID: 18344414817     PISSN: 0393974X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (22)

1. Koenig S, Gendelman HE, Orenstein JM, et al. Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy. Science 1986; 233: 1089-93.
2. Vazeux R, Brousse N, Jarry A, et al. AIDS subacute encephalitis. Identification of HIV-infected cells. Am J Pathol 1987; 126: 403-10.
3. Meltzer MS, Nakamura M, Hansen BD, Turpin JA, Kalter DC, Gendelman HE. Macrophages as susceptible targets for HIV infection, persistent viral reservoirs in tissue, and key immunoregulatory cells that control levels of virus replication and extent of disease. AIDS Res Hum Retroviruses 1990; 6: 967-71.
4. Armstrong JA, Horne R. Follicular dendritic cells and virus-like particles in AIDS-related lymphadenopathy. Lancet 1984; 2: 370-2.
5. Tschachler E, Groh V, Popovic M, et al. Epidermal Langerhans cells - a target for HTLV-III/LAV infection. J Invest Dermatol 1987; 88: 233-7.
6. McElrath MJ, Pruett JE, Cohn ZA. Mononuclear phagocytes of blood and bone marrow: comparative roles as viral reservoirs in human immunodeficiency virus type 1 infections. Proc Natl Acad Sci USA 1989; 86: 675-9.
7. Mattern CF, Murray K, Jensen A, Farzadegan H, Pang J, Modlin JF. Localization of human immunodeficiency virus core antigen in term human placentas. Pediatrics 1992; 89: 207-9.
8. Gabuzda DH, Ho DD, De la Monte SM, Hirsch MS, Rota TR, Sobel RA. Immunohistochemical identification of HTLV-III antigen in brains of patients with AIDS. Ann Neurol 1986; 20: 289-95.
9. Giulian D, Vaca K, Noonan CA. Secretion of neurotoxins by mononuclear phagocytes infected with HIV-1. Science 1990; 250: 1593-6.
10. Tyor WR, Power C, Gendelman HE, Markham RB. A model of human immunodeficiency virus encephalitis in seid mice. Proc Natl Acad Sci USA 1993; 90: 8658-62.
11. Lipton SA, Gendelman HE. Dementia associated with the acquired immunodeficiency syndrome. N Engl J Med 1995; 332: 934-40.
12. Crowe SM, Mills J, Kirihara J, Boothman J, Marshall JA, McGrath MS. Full-length recombinant CD4 and recombinant gp120 inhibit fusion between HIV infected macrophages and uninfected CD4-expressing T-lymphoblastoid cells. AIDS Res Hum Retroviruses 1990; 6: 1031-7.
13. Herbein G, Verdin E, Lovett JL, Van Lint C. Distinct mechanisms trigger apoptosis in human immunodeficiency. J Virol 1998; 72: 660-70.
14. Mastino A, Grelli S, Piacentini M, et al. Correlation between induction of lymphocyte apoptosis and prostaglandin E2 production by macrophages infected with HIV. Cell Immunol 1993; 152: 120-30.
15. Bagnarelli P, Valenza A, Menzo S, et al. Dynamics and modulation of human immunodeficiency virus type 1 transcripts in virus and in vivo. J Virol 1996; 70: 7603-13.
16. Cenci A, Perno CF, Menzo S, et al. Selected nucleotide sequence of the pol gene of the monocytotropic strain HIV-1 Ba-L. AIDS Res Hum Retrov 1997; 13: 629-32.
17. Aquaro S, Perno CF, Balestra E, et al. Inhibition of replication of HIV in primary monocyte/macrophages by different antiviral drugs and comparative efficacy in lymphocytes. J Leukoc Biol 1997; 62: 138-43.
18. Perno CF, Aquaro S, Rosenwirth B, et al. In vitro activity of inhibitors of late stages of the replication of HIV in chronically infected macrophages. J Leukoc Biol 1994; 56: 381-6.
19. th Conf Retro and-Opportun Infect 1997 Jan 22-26; pag. 199.
20. Perelson AS, Essunger P, Cao Y, et al. Decay characteristics of HIV-1-infected compartments during combination therapy. Nature 1997; 387: 188-91.
21. Sei S, Stewart SK, Farley M, et al. Evaluation of human immunodeficiency virus (HIV) type 1 RNA levels in cerebrospinal fluid and viral resistance to zidovudine in children with HIV encephalopathy. J Infect Dis 1996; 174: 1200-6.
22. Pialoux G, Fournier S, Moulignier A, Poveda JD, Clavel F Dupont B. Central nervous system as a sanctuary for HIV-1 infection despite treatment with zidovudine, lamivudine and indinavir. AIDS 1997; 11: 1302-3.